Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran: The Sociodemographic, Dietary and Psychological Determinants

  • Jafar Sadegh TABRIZI Tabriz Health Services Management Research Center, Faculty of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
  • Leila NIKNIAZ Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Homayoun SADEGHI-BAZARGANI Department of Statistics and Epidemiology, Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Mostafa FARAHBAKHSH Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
  • Zeinab NIKNIAZ Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Mahdieh ABBASALIZAD FARHANGI Drug applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Elham EGHBALI Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Keywords: Dietary intake; Dyslipidemia; Iran; Smoking; Anxiety


Abstract Background: As dyslipidemia is a preventable risk factor for Coronary heart disease (CHD), precise estimation of its prevalence and determinants is crucial for proper development of health actions. This population-based study aimed at investigating the socioeconomic, dietary and psychological determinants of dyslipidemia in Iran. Methods: The data (n=700) for this study were collected in 2015 as a part of the major Lifestyle Promotion Project (LPP) conducted in East Azerbaijan (urban and regional parts). The data for socio-demographic status, dietary information, and physical activity and anxiety levels were collected through validated questionnaires. Then, physical examinations including blood pressure, body mass index (BMI) and conicity index were performed. The levels of serum lipids were measured by enzymatic colorimetric methods. Results: The prevalence of hypercholesterolemia, high LDL-C, hypertriglyceridemia, low HDL-C and dyslipidemia was 29.4%, 10.3%, 62.3%, 41.4%, 83.3% respectively. The mean TC (184.3±41.2 vs. 174.5±38.1 mg/dl), LDL-C (94.6±30.3 vs. 88.1±28.7 mg/dl) and HDL-C (46.7±10.4 vs. 39.5±8.0 mg/dl) in women were significantly higher than men (P<0.05). However, the mean of TG (182.3±119.3 vs. 145.1±87.8 mg/dl) was significantly higher in men compared to women (P<0.05). Obesity, family history of dyslipidemia, sedentary lifestyle, smoking habits, salt intake, and anxiety were risk factors for different components of dyslipidemia in men and women. Conclusion: Dyslipidemia is a major health problem in northwest of Iran. Focusing on screening, regular drug intake, proper nutrition, physical activity, and changing lifestyles of patients with dyslipidemia are essential.    


1. Fesharakinia A, Zarban A, Sharifzadeh G-R (2008). Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran. Arch Iran Med, 11:598-601.
2. Voight BF, Peloso GM, Orho-Melander M, et al (2012). Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 380:572-580.
3. Fuentes R, Uusitalo T, Puska P et al (2003). Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil, 10:411-419.
4. Tabatabaei-Malazy O, Qorbani M, Samavat T et al (2014). Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. Int J Prev Med, 5:373-93.
5. Ni WQ, Liu XL, Zhuo ZP et al (2015). Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis, 14:71.
6. Tabrizi J-S, Farahbakhsh M, Sadeghi-Bazargani H, Nikniaz L (2016). Introducing the Objectives, Procedures and Structure of Lifestyle Promotion Project (LPP): Phase I. Depiction of Health, 7:1-7.
7. Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18:499-502.
8. Sharma SK, Ghimire A, Radhakrishnan J, et al (2011). Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens, 2011: 821971.
9. Prasad D, Kabir Z, Dash A, Das B (2012). Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res, 3:204-211.
10. Costa J, Borges M, Oliveira E et al (2003). Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part I. Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia= Portuguese journal of cardiology: an official journal of the Portuguese Society of Cardiology, 22:569-577.
11. Go AS, Mozaffarian D, Roger VL, et al (2013). Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation, 127:e6-e245.
12. Firmann M, Mayor V, Vidal PM et al (2008). The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord, 8:6.
13. Erem C, Hacihasanoglu A, Deger O et al (2008). Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine, 34:36-51.
14. Hollman G, Kristenson M (2008). The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population—Mainly a function of overweight? Eur J Cardiovasc Nurs, 7:21-26.
15. Navaei L, Mehrabi Y, Azizi F (2000). Epidemiology of hyperlipidemia, obesity and increased blood pressure in rural areas of Tehran Province. Iran J Endocrinol Metab, 2:253-62.
16. Barzygar A, Tehrani H (1997). Prevalence of atherosclerosis risk factors in the Some’esara city in 1996. J Kerman Univ Med Sci, 4:182-9.
17. Bahreynian M, Esmaillzadeh A (2012). Quantity and quality of carbohydrate intake in Iran: a target for nutritional intervention. Arch Iran Med, 15:648-649.
18. Qi L, Ding X, Tang W et al (2015). Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing, China. Int J Environ Res Public Health, 12:13455-13465.
19. Sharma U, Kishore J, Garg A et al (2013). Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol, 7:653-660.
20. Nguyen NT, Magno CP, Lane KT et al (2008). Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg, 207:928-934.
21. Argani H, Mahdavi R, Ghorbani-haghjo A et al (2014). Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients. J Trace Elem Med Biol, 28 (1): 35-38.
22. Bolhuis DP, Costanzo A, Newman LP, Keast RS (2016). Salt Promotes Passive Overconsumption of Dietary Fat in Humans. J Nutr, 146:838-845.
23. Landén M, Baghaei F, Rosmond R et al (2004). Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety. Psychoneuroendocrinology, 29:1037-1046.
24. Kokkinos PF, Holland JC, Narayan P et al (1995). Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men: a dose-response relationship. Arch Intern Med, 155:415-420.
25. Cheraghian B, Asadi-Lari M, Mansournia MA, et al (2014). Prevalence and associat-ed factors of self-reported hypertension among Tehran adults in 2011: a popula-tion-based study (Urban HEART-2). Med J Islam Repub Iran, 28: 105.
How to Cite
TABRIZI JS, NIKNIAZ L, SADEGHI-BAZARGANI H, FARAHBAKHSH M, NIKNIAZ Z, ABBASALIZAD FARHANGI M, EGHBALI E. Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran: The Sociodemographic, Dietary and Psychological Determinants. Iran J Public Health. 48(5):925-933.
Original Article(s)